ViaLase announced the first patient was treated in a U.S. IDE clinical trial evaluating its femtosecond laser trabeculotomy ...

Canaloplasty has emerged as a viable surgical intervention for the management of open-angle glaucoma, offering an alternative to traditional procedures such as trabeculectomy. This non-penetrating ...

A risk score incorporating genetic variants for open-angle glaucoma is accurate enough to help with diagnosis of the condition, an interim study reveals. Although hundreds of genetic changes are ...

Glaucoma is both preventable, with early treatment, and the leading cause of blindness in those over 60. Additionally, the incidence of glaucoma and its harms are greater in both our Black and ...

It's one of the most common causes of vision loss, and one of the easiest to overlook. Glaucoma symptoms develop so gradually that many people don't realize their sight is slipping away until ...

Taking the medication metformin hydrochloride was associated with reduced risk of developing the sight-threatening disease open-angle glaucoma in people with diabetes, according to a study published ...

The MarketWatch News Department was not involved in the creation of this content.-- The first VisiPlate surgery in the US for the SAPPHIRE Trial was performed by Dr. Snyder of Sac ...

Please provide your email address to receive an email when new articles are posted on . Patients with migraine aged younger than 40 years had higher risk for open-angle glaucoma onset vs. those aged ...

Glaucoma is not fatal. Without treatment, glaucoma can cause significant vision loss and eventually blindness, but early treatment can help protect vision and slow the progression of the disease.

Open-angle glaucoma represents one of the most prevalent causes of irreversible sight loss globally. The principal aim of treatment is to lower intraocular pressure (IOP) to slow the progression of ...

Avisi Technologies, Inc., an ophthalmic medical device company advancing novel, sight-saving technologies, announces the ...